| Financial Year |
March 31 2023 |
| Monetary Funds |
3,729,016,050.04 |
| Held-for-trading Financial Assets |
38,120,460.00 |
| Notes Receivable |
38,612,435.52 |
| Accounts Receivable |
2,850,290,331.99 |
| Advances to Suppliers |
327,062,177.30 |
| Other Receivables |
62,722,548.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,915,430,680.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
133,996,588.61 |
| Total Current Assets |
10,098,030,073.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
109,859,696.15 |
| Investment Properties |
330,686,923.41 |
| Fixed Assetes |
2,787,432,073.95 |
| Under-construction Projects |
1,261,485,171.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
515,814,445.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
27,874.06 |
| Deferred Income Tax Assets |
145,002,244.00 |
| Other Non-Current Assets |
963,801,718.02 |
| Sub-Total of Non-Current Assets |
6,190,459,471.54 |
| Total Assets |
16,288,489,545.41 |
| Short-Term Loans |
1,332,370,747.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
866,800,807.90 |
| Accounts Payable |
2,776,453,968.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,763,710.56 |
| Taxes Payable |
29,050,925.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,970,236.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
679,474,233.35 |
| Other Current Liabilities |
89,118,349.82 |
| Sub-Total of Current Liabilities |
6,379,965,981.14 |
| Long-term Loans |
124,821,174.42 |
| Bonds Payable |
2,079,165,020.72 |
| Long-Term Accounts Payable |
357,868,106.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,902,691.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,650,236,094.22 |
| Total Liabilities |
9,030,202,075.36 |
| Paid-In Capital(Or Share Stock) |
3,896,339,676.00 |
| Capital Surplus |
871,742,163.68 |
| Surplus Reserve |
284,772,403.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,795,640,197.44 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,258,287,470.05 |
| Owner's Equity（Stockholder's Equity） |
7,258,287,470.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,288,489,545.41 |
